| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 10/20/2026 | ±3.3% | +3.0% | over-priced |
| 07/01/2026 | ±5.3% | +6.7% | under-priced |
| 04/02/2026 | ±5.0% | +1.3% | over-priced |
| 01/05/2026 | ±1.6% | +0.5% | over-priced |
| 10/22/2025 | ±3.2% | -1.4% | over-priced |
| 07/03/2025 | ±2.0% | +0.1% | over-priced |
| 04/04/2025 | ±2.4% | -4.8% | under-priced |
| 01/08/2025 | ±1.9% | -0.5% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q4 FY2026 | — | $635M | $121M |
| Q3 FY2026 | $3.50 | $623M | $127M |
| Q2 FY2026 | $3.59 | $611M | $133M |
| Q1 FY2026 | $4.06 | $608M | $153M |
FDS (FDS) reports in 83 days, with the next report estimated for 01/18/2027. Across the last 8 reports, options priced an average ±3.1% earnings move while the stock actually moved 2.3% on average — the market has systematically over-priced FDS's earnings risk. Fundamentals into the print: EPS up 0.0% year-over-year, revenue up 6.3%. QuantLogix's live 5-factor engine currently reads FDS as a buy at 62/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →